Advicenne Pharmaceuticals' IPO

Advicenne Pharmaceuticals raised a round of funding on December 07, 2017. Investors include Public.

Advicenne is a pharmaceutical company that develops drugs for children with neurological disorders such as epilepsy as well as renal or orphan diseases. The Company's products and treatments are safe,…

Articles about Advicenne Pharmaceuticals' IPO: